Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Konrad Siegel is active.

Publication


Featured researches published by Konrad Siegel.


Chemistry: A European Journal | 1998

First Total Synthesis of Dihydroxerulin, a Potent Inhibitor of the Biosynthesis of Cholesterol

Konrad Siegel; Reinhard Brückner

Dihydroxerulin (5) is a noncytotoxic inhibitor of cholesterol biosynthesis. In spite of being achiral and devoid of OH groups, it was synthesized efficiently in 2×5 steps in two linear sequences plus one terminating step, from the optically active, multiply hydroxylated L-gulonolactone via the key intermediates 1–4. 1H NMR spectroscopy revealed that the C8=C9 bond of synthetic and natural 5 is trans-substituted.


ChemInform | 1999

Stereoselective Syntheses of γ-Lactones and γ-Alkylidene- Butenolides

Christian Harcken; Thilo Berkenbusch; Stefan Braukmüller; Andreas Umland; Konrad Siegel; Felix Görth; Frank von der Ohe; Reinhard Brückner

Five-membered ring lactones abound in nature and have ever since challenged synthetic chemists.1,3 They comprise butanolides (1), butenolides (2), α-alkylidenebutanolides (3), and γ-alkylidenebutenolides (4; Fig. 1). We have developed versatile routes to such compounds. They encompass only a few steps and ensure a high degree of stereocontrol at all stereogenic sp 3 centers and C=C bonds. In addition they allow to vary the substituents R, R′, and R″ considerably. Therefore, we were able to synthesize butanolides and butenolides which differed structurally from one another distinctly.


Chemistry: A European Journal | 2005

Stereoselective Syntheses of Dihydroxerulin and Xerulinic Acid, Anti‐Hypocholesterolemic Dyes from the Fungus Xerula melanotricha

Achim Sorg; Konrad Siegel; Reinhard Brückner


Synlett | 1999

FIRST SYNTHESIS OF XERULIN, AN INHIBITOR OF THE BIOSYNTHESIS OF CHOLESTEROL

Konrad Siegel; Reinhard Brückner


Archive | 2010

Method for producing methyl-{4,6-diamino-2-[1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridino-3-yl]pyrimidino-5-yl}methyl carbamate and its purification for use thereof as pharmaceutical substance

Franz-Josef Mais; Joachim Rehse; Winfried Joentgen; Konrad Siegel


Archive | 2010

Process for preparing methyl {4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b] pyridin-3-yl]pyrimidin-5-yl}methylcarbamate and its purification for use as pharmaceutically active compound

Franz-Josef Mais; Joachim Rehse; Winfried Joentgen; Konrad Siegel


Archive | 2010

Process for preparing methyl {4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl}carbamate and its purification for use as pharmaceutically active compound

Franz-Josef Mais; Joachim Rehse; Winfried Joentgen; Konrad Siegel


Archive | 2010

Method for producing methyl-{4,6-diamino-2-[1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridino-3-yl]pyrimidino-5-yl} carbamate and its purification for use thereof as pharmaceutical substance

Franz-Josef Mais; Joachim Rehse; Winfried Joentgen; Konrad Siegel


Archive | 2011

Method for producing N-sulfonyl-substituted oxindoles

Gunter Karig; Mark James Ford; Konrad Siegel; Stefan Schnatterer


Synlett | 2004

A novel access to γ-alkylidenebutenolides: Sequential stille couplings of dibromomethylenebutenolides

Achim Sorg; Konrad Siegel; Reinhard Brückner

Collaboration


Dive into the Konrad Siegel's collaboration.

Top Co-Authors

Avatar

Franz-Josef Mais

Bayer HealthCare Pharmaceuticals

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Franz-Josef Mais

Bayer HealthCare Pharmaceuticals

View shared research outputs
Top Co-Authors

Avatar

Achim Sorg

University of Freiburg

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge